Project Grant K01DA063935
Award Date 8/1/25
Completion Date 7/31/30
Dollars Obligated $182K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Maryland, USA
Similar Awards
- This Project Grant award of $783,300 from the National Institute on Drug Abuse (CFDA 93.279 - Drug Use and Addiction Research Programs) will fund a research study titled "Informing Best Practices for Substance-Use Treatment with Real-World Evidence for People with Opioid Use Disorder and HIV (STRONG)". The study will be conducted by The Johns Hopkins University in Maryland and aims to comprehensively characterize opioid use disorder (OUD) treatment, co-occurring substance use and...
- This Project Grant award of $722,917 from the National Institute on Drug Abuse (NIDA), part of the Department of Health and Human Services, will fund a 5-year study to evaluate a new approach for dispensing methadone to incarcerated individuals with opioid use disorder (OUD) in three state prison systems. The project aims to support widespread implementation of the hospital/clinic designation, which allows carceral facilities to stock and dispense methadone for OUD treatment, by launching a...
- This $147,486 federal Project Grant award from the National Institute on Drug Abuse (CFDA 93.279 - Drug Use and Addiction Research Programs) will support a mixed-methods study examining the predictors and outcomes of methadone and buprenorphine receipt during incarceration. The study will analyze a longitudinal database on health service use and outcomes among 4,558 incarcerated individuals who received these medications from 2016-2023 at a unified jail and prison system in the Northeast....
- This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), will support a study to characterize treatment utilization and identify predictors of treatment engagement during the critical community re-entry period for adults with opioid use disorder (OUD) who have completed residential OUD treatment. The $147,486 award, with a performance period from December 20, 2024 to August 31, 2026, will leverage innovative...
- This $683,222 Project Grant awarded by the National Institute on Aging (CFDA 93.866 - Aging Research) aims to analyze access to medications to treat opioid use disorder (OUD) among Medicare beneficiaries. The study will assess disparities in access to medication-assisted treatment (MOUD) and evaluate the impact of state and federal policies on MOUD utilization and health outcomes. Key areas of focus include examining how provider quality contributes to MOUD access disparities, as well as...
- This federal Project Grant award of $193,644 from the National Institute on Drug Abuse (CFDA 93.279 - Drug Use and Addiction Research Programs) supports a multi-level epidemiological study conducted by The Trustees of Columbia University in the City of New York. The study aims to examine how individuals transition through different substance use profiles, the determinants of these transitions, and polysubstance use profiles at increased risk of overdose. The research plan leverages the...
- This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $823,809 to the University of Pittsburgh to develop and validate a suite of multidimensional measures of access to Medications for Opioid Use Disorder (MOUD) across U.S. states and the District of Columbia. The primary objectives are to: Create a Small Area Multidimensional MOUD Access (SAMMA) measure suite using public data sources. Validate and...
- The federal Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $439,180 to The Johns Hopkins University to investigate the role of dopaminergic neuron-glial interactions in the striatum in the context of HIV infection and substance use disorders. The research aims to deconvolute the complex interplay between HIV, methamphetamine use, and alterations in dopamine signaling pathways, which can contribute...
- The Johns Hopkins University was awarded a $634,617 project grant from the National Institute on Drug Abuse (CFDA 93.279 Drug Use and Addiction Research Programs) on July 15, 2025. The grant will support research to understand the neural basis of the transition from goal-directed to habitual behavior, which is thought to rely on a shift in control from the dorsomedial to dorsolateral striatum. The research project aims to leverage a novel behavioral paradigm called "volitional...
- This $189,500.00 Project Grant award was provided by the National Institute on Drug Abuse (NIDA), which is part of the National Institutes of Health (NIH), under the Drug Use and Addiction Research Programs (CFDA 93.279). The project aims to determine the extent to which cardiovascular disease (CVD) affects people with opioid use disorder (OUD) and identify ways to prevent CVD in this population. To achieve this, the project will: 1) Examine the relationship between CVD and OUD using Transformed...